Survivor study for young nasopharyngeal carcinoma patients
Part of Cancer, Ear, nose & throat clinical trials.
This study looks at the long-term health and survival of people who had nasopharyngeal carcinoma (a type of cancer in the back of the nose and throat) before age 21. It helps researchers understand how to better care for young survivors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with a specific type of nasopharyngeal carcinoma (non-keratinizing, WHO type II or III) before your 21st birthday.
- You were treated at one of the participating medical centers.
- You or your sibling must agree to join the study and sign a consent form.
- You are not currently in another blinded clinical trial.
- Your doctors can access your tumor response and survival data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system responds to radiation therapy for nasopharyngeal cancer. It will use scans and blood tests to find markers that might predict how well treatment works.
This study looks at tissue and blood samples from people already treated for nasopharyngeal carcinoma to find markers that predict how well treatment works and to identify new ways to treat the cancer. It may help doctors personalise care in the future.
This study looks at how well the current cancer staging system works for nasopharyngeal cancer. If you have been diagnosed with this type of cancer between October 2025 and September 2026, you may be able to join.
This trial tests a new way of managing advanced nasopharyngeal cancer that has spread to the neck after radiation therapy. It uses regular imaging and exams to guide a less invasive neck surgery, aiming to remove any remaining cancer while preserving healthy tissue.
This study looks at how well nasopharyngeal cancer (NPC) responds to the first round of chemotherapy before other treatments. It aims to see if the amount of tumor shrinkage can help predict outcomes and guide future care for people with advanced NPC.
This study helps doctors predict which patients with nasopharyngeal cancer (a cancer of the upper throat) will benefit most from additional chemotherapy after radiation treatment. It uses a special blood test and imaging to create a personalized risk score for each patient.
Hear when a new NPC Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.